Sorrento Therapeutics, Inc. (SRNE) News Headlines

▮ More

Date

Headline

1/20/2022 9:30:55 AM Sorrento Says Covishield Potently Neutralizes Omicron And Omicron Variants Of Sars-Cov-2

1/20/2022 9:03:19 AM Sorrento Therapeutics Announces Covishield Potently Neutralizes Omicron And Omicron Variants Of Sars-Cov-2

12/27/2021 9:46:44 AM Sorrento's COVISTIX COVID-19 Virus Rapid Antigen Detection Test Detects Omicron Variant

6/12/2021 1:30:42 PM Sorrento Gets UK Authorization To Conduct Phase 2 Trial For COVI-DROPS; Shares Up

4/5/2021 9:07:36 AM Sorrento Therapeutics To Acquire ACEA Therapeutics

3/2/2021 5:18:56 PM Sorrento Gets FDA Approval For Phase 1 Study For COVID Treatment; Shares Up 5%

1/28/2021 2:49:22 AM AGTC Sheds Light On Achromatopsia Trials, LLY, VIR And GSK Team Up, CVM Turns Head As It Awaits Data

1/27/2021 10:29:57 AM Stock Alert: Sorrento Therapeutics Up 14%

1/27/2021 2:56:46 AM AGIO's ACTIVATE-T Hits Goals, EDSA Catches Eye, JNJ Provides Rosy Outlook, VXRT On Watch

1/26/2021 9:02:52 PM Sorrento Announces Positive Preliminary Phase 1b Results On ICU COVID-19 Patients Treatment;stock Up

1/26/2021 7:42:56 PM Sorrento Reports Positive Preliminary Results Of Phase 1b Study Of COVI-MSC For Treatment Of ICU COVID-19 Patients

1/20/2021 5:40:44 AM Pre-market Movers In Healthcare Sector: LCTX, DARE, SRNE, NOVN, HSTO…

12/22/2015 8:34:03 AM FBR Capital Markets Initiates Sorrento Therapeutics, Inc. (SRNE) At Outperform With $22 Price Target

Older Articles